| Product Code: ETC13129797 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Non-Alcoholic Steatohepatitis Treatment Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Non-Alcoholic Steatohepatitis Treatment Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Non-Alcoholic Steatohepatitis Treatment Market - Industry Life Cycle |
3.4 Europe Non-Alcoholic Steatohepatitis Treatment Market - Porter's Five Forces |
3.5 Europe Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Europe Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Europe Non-Alcoholic Steatohepatitis Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Non-Alcoholic Steatohepatitis Treatment Market Trends |
6 Europe Non-Alcoholic Steatohepatitis Treatment Market, 2021 - 2031 |
6.1 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Vitamin E and Pioglitazone, 2021 - 2031 |
6.1.3 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Obeticholic Acid (OCA), 2021 - 2031 |
6.1.4 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Lanifibranor, 2021 - 2031 |
6.1.5 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Semaglutide, 2021 - 2031 |
6.1.6 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Resmetirom, 2021 - 2031 |
6.1.7 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Aramchol, 2021 - 2031 |
6.1.8 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Cenicriviroc, 2021 - 2031 |
6.1.9 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.2.3 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Retail and Specialty Pharmacies, 2021 - 2031 |
6.2.4 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Others, 2021 - 2031 |
7 Europe Non-Alcoholic Steatohepatitis Treatment Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.1 United Kingdom (UK) Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.2 Germany Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.3 France Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.4 Poland Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.5 Spain Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.2.6 Rest of Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By Drug Type, 2021 - 2031 |
7.3 Europe Non-Alcoholic Steatohepatitis Treatment Market Revenues & Volume Share, By End-use, 2021 & 2031F |
7.3.1 United Kingdom (UK) Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.2 Germany Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.3 France Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.4 Poland Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.5 Spain Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
7.3.6 Rest of Europe Non-Alcoholic Steatohepatitis Treatment Market, Revenues & Volume, By End-use, 2021 - 2031 |
8 Europe Non-Alcoholic Steatohepatitis Treatment Market Key Performance Indicators |
9 Europe Non-Alcoholic Steatohepatitis Treatment Market - Export/Import By Countries Assessment |
10 Europe Non-Alcoholic Steatohepatitis Treatment Market - Opportunity Assessment |
10.1 Europe Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
10.3 Europe Non-Alcoholic Steatohepatitis Treatment Market Opportunity Assessment, By End-use, 2021 & 2031F |
11 Europe Non-Alcoholic Steatohepatitis Treatment Market - Competitive Landscape |
11.1 Europe Non-Alcoholic Steatohepatitis Treatment Market Revenue Share, By Companies, 2022 |
11.2 Europe Non-Alcoholic Steatohepatitis Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |